• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Phenylpyrrolidines

Introduction to 2,5-Pyrrolidinedione, 1-(4-aminophenyl)- (CAS No. 34373-09-6) and Its Emerging Applications in Chemical Biology

2,5-Pyrrolidinedione, 1-(4-aminophenyl)-, identified by the Chemical Abstracts Service Number (CAS No.) 34373-09-6, is a heterocyclic compound that has garnered significant attention in the field of chemical biology due to its unique structural and functional properties. This compound belongs to the pyrrolidinedione class, which is characterized by a five-membered ring containing two nitrogen atoms and a carbonyl group. The presence of an amino phenyl substituent at the 1-position introduces additional reactivity and potential biological activity, making it a valuable scaffold for drug discovery and material science applications.

The structure of 2,5-Pyrrolidinedione, 1-(4-aminophenyl)- exhibits remarkable versatility, allowing for modifications at multiple positions that can fine-tune its chemical and biological behavior. The amino group at the phenyl ring provides a site for further functionalization, enabling the synthesis of derivatives with enhanced solubility, binding affinity, or metabolic stability. Such modifications are crucial in medicinal chemistry, where optimizing pharmacokinetic profiles is often essential for therapeutic efficacy.

Recent advancements in computational chemistry and molecular modeling have facilitated a deeper understanding of the interactions between 2,5-Pyrrolidinedione, 1-(4-aminophenyl)- and biological targets. Studies have demonstrated its potential as an intermediate in the synthesis of small-molecule inhibitors targeting various disease-related pathways. For instance, researchers have explored its utility in developing kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The heterocyclic core of this compound mimics natural product scaffolds known to exhibit potent biological activity.

The chemical reactivity of 2,5-Pyrrolidinedione, 1-(4-aminophenyl)- makes it a promising candidate for further derivatization. The amino phenyl group can undergo nucleophilic substitution reactions, allowing for the introduction of diverse functional moieties such as carboxylic acids, alcohols, or thiols. These modifications can enhance binding interactions with biological targets or improve pharmacokinetic properties. Additionally, the compound’s ability to form hydrogen bonds due to the presence of both an amide-like carbonyl group and an amino group makes it an excellent candidate for designing molecules with high specificity.

In the realm of material science, 2,5-Pyrrolidinedione, 1-(4-aminophenyl)- has been investigated for its potential applications in polymer chemistry. Its incorporation into polymer backbones can impart unique properties such as increased thermal stability or biodegradability. Researchers have also explored its use in designing stimuli-responsive materials that can undergo conformational changes upon exposure to external stimuli like light or pH changes. Such materials are increasingly relevant in drug delivery systems and smart coatings.

The synthesis of 2,5-Pyrrolidinedione, 1-(4-aminophenyl)- involves multi-step organic transformations that highlight its synthetic utility. Common synthetic routes include condensation reactions between appropriately substituted precursors followed by cyclization steps to form the pyrrolidinedione core. Advances in green chemistry have led to the development of more sustainable synthetic methods that minimize waste and hazardous byproducts. These environmentally friendly approaches align with the growing emphasis on sustainable practices in pharmaceutical manufacturing.

Biologically speaking, 2,5-Pyrrolidinedione, 1-(4-aminophenyl)- has shown promise as a tool compound in biochemical assays. Its ability to interact with enzymes and receptors has been exploited in high-throughput screening campaigns to identify novel drug candidates. Furthermore, preliminary studies suggest that it may exhibit antimicrobial properties, making it a candidate for developing new antibiotics or antifungal agents. The growing threat of antibiotic resistance underscores the need for innovative approaches to combat microbial infections.

The pharmacological potential of derivatives derived from 2,5-Pyrrolidinedione, particularly those featuring the 1-(4-aminophenyl)- moiety, has been extensively studied. Researchers have synthesized analogs targeting neurological disorders such as Alzheimer’s disease and Parkinson’s disease by leveraging the compound’s ability to cross the blood-brain barrier efficiently. The structural flexibility of this scaffold allows for fine-tuning interactions with specific protein targets involved in these conditions.

From an industrial perspective, 2,5-Pyrrolidinedione,1-(4-aminophenyl)- presents opportunities for scaling up production processes to meet growing demand in pharmaceuticals and specialty chemicals markets. Continuous flow chemistry techniques have been adapted for synthesizing this compound more efficiently, reducing production costs while maintaining high purity standards required for pharmaceutical applications. Such innovations are crucial for ensuring accessibility and affordability of advanced therapies.

The future directions involving CAS No.,34373-09-6, encompass exploring its role in emerging fields such as nanomedicine where it could serve as a component in drug delivery systems or diagnostic agents. Its compatibility with various functional groups makes it adaptable to diverse applications beyond traditional pharmaceuticals, including agrochemicals where tailored derivatives might offer novel solutions against pests or plant pathogens.

• 4789-09-7(1-Phenylpiperidin-2-one)
• 13691-22-0(1-(4-Aminophenyl)pyrrolidin-2-one)
• 4641-57-0(1-Phenyl-2-pyrrolidone)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)